Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Acta Haematologica|February 12, 2025
Distress and Care Utilization in Patients with Myeloproliferative NeoplasmsRushil Virendra Patel, Danielle Boselli, Patrick L Meadors, et al.
Transplantation and Cellular Therapy|September 27, 2024
Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell TransplantationMichael R Grunwald, Wei Sha, Jiaxian He, et al.
Vaccine: X|April 6, 2023
COVID-19 vaccine uptake trends in SARS-CoV-2 previously infected cancer patientsZainab Shahid, Alicia L Patrick, Michelle L Wallander, et al.
Clinical and Translational Science|December 24, 2022
First-in-human study of JNJ-63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemiaMichael Boyiadzis, Pinkal Desai, Nikki Daskalakis, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 24, 2018
Higher Incidence of Hemorrhagic Cystitis Following Haploidentical Related Donor Transplantation Compared with Matched Related Donor TransplantationOlivia R Copelan, Srinivasa R Sanikommu, Jigar S Trivedi, et al.
Clinical Pharmacology and Therapeutics|September 25, 2019
Evaluation of CYP2C19 Genotype-Guided Voriconazole Prophylaxis After Allogeneic Hematopoietic Cell TransplantJai N Patel, Issam S Hamadeh, Myra Robinson, et al.
Leukemia|October 19, 2021
Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter studySiddharth Kunte, Lisa Rybicki, Auro Viswabandya, et al.
Blood Advances|October 25, 2019
Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemiaPaul Milne, Charlotte Wilhelm-Benartzi, Michael R Grunwald, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2019
Effect of CYP3A4, CYP3A5, and ABCB1 Polymorphisms on Intravenous Tacrolimus Exposure and Adverse Events in Adult Allogeneic Stem Cell Transplant PatientsIssam S Hamadeh, Qing Zhang, Nury Steuerwald, et al.
Blood|April 25, 2013
Phase 2 study of azacytidine plus sorafenib in patients with acute myeloid leukemia and FLT-3 internal tandem duplication mutationFarhad Ravandi, Mona Lisa Alattar, Michael R Grunwald, et al.
Pageof 9